Tratamiento de los problemas psíquicos relacionados con el consumo de drogas de diseño (MDMA, Éxtasis)
- M. A. Landabaso Vazquez 1
- J. M. Jiménez Lerma 2
- J. Sanz Etxebarria 2
- 1 Centro de Salud Mental (Drogodependencias) de Barakaldo
- 2 Centro de Tratamiento de Toxicómanos de Alava y Alto Deba. OSAKIDETZA- Servicio Vasco de Salud. APCAD (Asociación de Profesionales de Centros de Atención de Drogodependencias del País Vasco).
ISSN: 1575-0973
Argitalpen urtea: 1999
Alea: 1
Zenbakia: 2
Orrialdeak: 110-116
Mota: Artikulua
Beste argitalpen batzuk: Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías
Laburpena
Objective: evaluated a first election pharmacological treatment for flasback- Psychosis after misuse of MDMA. Material and methods: longitudinal study. The study was assesed using the Brief Psychiatric Rating Scale (BPRS), the Hamilton Rating Scale for Depression, and the Clinical Global Impresion (CGI), at baseline, first moth, 3rd month and 6th month. Subjets: 38 patients presenting between June 1997 and February 1998, with flashback-psychosis after misuse of MDMA; all of them recibed Olanzapine; 6 patients drop-out treatment. Results: the reduction from baseline to endpoint was significant (p < 0.001) in all scales; the improvement was clearly higher in the first month. No side effects was observed. Conclusions: the study showed that Olanzapine can be used as first election neuroleptic in flashback-Psychosis after misuse of MDMA.